arrow
M

Matthew R. Cooperberg

university of california
H指数:86
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A WEIGHTED SCALE TO IDENTIFY EMBARK-LIKE PATIENTS AT HIGH-RISK FOR PROGRESSION AND MORTALITY AFTER BIOCHEMICAL RECURRENCE (BCR) WHO MAY BENEFIT FROM EARLY INTENSIFIED ADT

一种加权评分系统,用于识别在生化复发(BCR)后可能受益于早期强化雄激素剥夺疗法(ADT)的高风险进展和死亡率的EMBARK样患者

2026-05-010
PRE
ASSOCIATION OF BIOPSY-BASED GENOMIC CLASSIFIER AND INITIAL TREATMENT FOR PROSTATE CANCER: RESULTS FROM A NATIONAL CLINICAL-GENOMIC LINKAGE

基于活检的基因组分类器与前列腺癌初始治疗的关系:一项国家临床-基因组关联研究的结果

2026-05-010
PRE
GENOMIC CLASSIFIER RESULTS AND USE OF POST-PROSTATECTOMY TREATMENT AMONG A NATIONAL COHORT OF PATIENTS WITH PROSTATE CANCER

前列腺癌患者全国队列中基因组分类器结果及术后治疗的应用

2026-05-010
PRE
ARE WE OPERATING ON THE SAME PATIENTS OVER THE PAST 2 DECADES? 20-YEAR TRENDS IN RADICAL PROSTATECTOMY DEMOGRAPHICS, CLINICOPATHOLOGY, AND OUTCOMES FROM A TERTIARY ACADEMIC CENTER AND MULTI-INSTITUTIONAL COLLABORATIVE

过去20年我们是否在为同一类患者进行手术?来自三级学术中心和多家机构合作的数据显示,根治性前列腺切除术的人口统计学特征、临床病理学和结局的20年趋势

2026-05-010
PRE
Association between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis

基线前列腺MRI PI-RADS分类与主动监测期间Gleason分级升级风险之间的关联:一项系统评价和荟萃分析

2026-02-150
PRE
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes

ANPEP的下调与侵袭性前列腺癌及不良疾病特异性预后相关

2025-12-260
OAAI
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

表征全人群基因组风险分布,以开发用于临床局部前列腺癌患者预后判断的新型临床-基因组风险系统

2025-12-090
OA
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial

Stockholm3 与前列腺特异性抗原在前列腺癌筛查中的比较:来自 STHLM3 试验的 9 年随访结果,表明提高了侵袭性癌的检出率并减少了过度诊断

2025-10-160
OAAI
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'

回复:“前列腺癌伴有良好组织学特征不等同于前列腺癌惰性发展”

2025-10-010
OA